Brief: Mithra Pharmaceuticals: Presentation Of Donesta® Phase 3 Topline Efficacy Results At 20Th ISGE World Congress
May 12 (Reuters) - Mithra Pharmaceuticals SA MITRA.BR :
* PRESENTATION OF DONESTA® PHASE 3 TOPLINE EFFICACY RESULTS
AT THE
20TH ISGE WORLD CONGRESS
Source text: https://bit.ly/3wj19rL
Further company coverage: MITRA.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Mithra Pharmaceuticals SA
See all newsBrief: Mithra Sells Estetra, Neuralis, Specific Assets To Gedeon Richter for EUR 175 Mln
Brief: Mithra Receives Additional EUR 2.5 Million To Advance Monetization
Brief: Mithra Secures Court Protection Measures To Advance Monetization Process
Brief: Mithra Pharmaceuticals Achieves LPR In Estetrol Skin Study
Brief: Mithra Applies To Liege Company Court For A "Transfer Under Judicial Supervision" For Mithra CDMO